regulatory
confidence high
sentiment negative
materiality 0.60
MetaVia Inc. (MTVA): Nasdaq/NYSE listing notice — NeuroBo gets 180-day Nasdaq bid-price extension to Feb 5, 2024; still below $1.00
MetaVia Inc.
- Nasdaq granted 180-day extension to Feb 5, 2024 to regain $1.00 minimum bid price.
- Stockholders approved reverse stock split (1:5 to 1:8) on June 28, 2023; board may implement.
- If not compliant by Feb 5, 2024, Nasdaq will issue delisting notice; company can appeal.
- Updated risk factors highlight potential delisting impact on liquidity and capital raising.